About me
Dr. David R. Goldsmith is an Associate Professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine and is the Associate Program Director for the Psychiatry Residency Research Track. He is also on Faculty in the Emory Behavioral Immunology Program. Dr. Goldsmith’s research program investigates the impact of inflammatory markers on brain reward circuitry, motivational deficits, and negative symptoms in patients with schizophrenia. He is currently funded by an R01 from the National Institute of Mental Health to use the TNF-antagonist infliximab in an experimental medicine study testing its effects on brain circuitry and behavior, which builds on data collected during his K23 Career Development Award. Clinically, Dr. Goldsmith co-directs the Clinical and Research Program for Psychosis at Grady and is the Director of the PSTAR (Persistent Symptoms: Treatment, Assessment, and Recovery) Clinic where he treats patients with persistent symptoms of psychosis. Dr. Goldsmith serves as an Associate Editor of Schizophrenia Research and is on the Editorial Board of Brain, Behavior, and Immunity. He is also an Associate Member of the American College of Neuropsychopharmacology. He has been recognized a number of times for his research and teaching including two Deans Teaching Awards from the Emory University School of Medicine in addition to awards from the Schizophrenia International Research Society and the Society of Biological Psychiatry.
or sign up with email →
Create a custom schedule.
Take it with you on mobile.
Get listed in the directory.
